During the past decade, Centro Integrado de Oncologia de Curitiba conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centro Integrado de Oncologia de Curitiba" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Centro Integrado de Oncologia de Curitiba" are "Abiraterone Acetate" (1 trials), "Androgens" (1 trials), "Antineoplastic Agents" (1 trials), "Antineoplastic Agents, Hormonal" (1 trials) and "Breast Neoplasms" (1 trials). Many other conditions were trialed in "Centro Integrado de Oncologia de Curitiba" in a lesser frequency.

Most popular intervention types in "Centro Integrado de Oncologia de Curitiba" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Abemaciclib" (1 trials), "Abiraterone" (1 trials), "Anastrozole" (1 trials), "Bendamustine" (1 trials) and "Exemestane" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centro Integrado de Oncologia de Curitiba" are 2 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Centro Integrado de Oncologia de Curitiba". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Centro Integrado de Oncologia de Curitiba, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centro Integrado de Oncologia de Curitiba, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".